(1) If the issue size exceeds five hundred crore rupees, the issuer shall make arrangements for the use of proceeds of the issue to be monitored by a public financial institution or by one of the scheduled commercial banks named in the offer document as bankers of the issuer:
Provided that nothing contained in this clause shall apply to an issue of specified securities made by a bank or public financial institution .
The monitoring agency shall submit its report to the issuer in the format specified in on a quarterly basis, till at least ninety five percent of the proceeds of the issue, excluding the proceeds under offer for sale and amount raised for general corporate purposes, have been utilized.
(2) The monitoring agency shall submit its report to the issuer in the format specified in Schedule IX on a half yearly basis, till the proceeds of the issue have been fully utilised.
The Board of Directors and the management of the company shall provide their comments on the findings of the monitoring agency as specified in .
The issuer shall, within forty five days from the end of each quarter, publically disseminate the report of the monitoring agency by uploading the same on its website as well as submitting the same to the stock exchange(s) on which its equity shares are listed.
SEBI (Issue of Capital and Disclosure Requirements) (Fourth Amendment) Regulations, 2010, w.e.f. 12.11.2010
SEBI (Issue of Capital and Disclosure Requirements) (Second Amendment) Regulations, 2017, w.e.f. 31.5.2017.
ICDR-Schedule IX
Front Page:
Report of the Monitoring Agency
Name of the Issuer:
For quarter ended:
Name of the Monitoring Agency:
(a) Deviation from the objects:
– Utilization different from Objects stated in OD but in line with change of objects approved by shareholders’ resolution; or
– Utilization neither in line with Objects stated in OD nor approved by shareholders’ resolution
– In case of no deviation, the fact would be stated.
(b) Range of Deviation*:
Indicate range of percentage deviation from the amount of issue proceeds earmarked for objects. For example, up to 10%, 10 – 25%, 25-50%, 50-75%, 75-100%, not ascertainable etc.
* Range of Deviation may be computed by taking weighted average of financial deviation of each object in the ratio of issue proceeds allocated for it. Non-financial deviation may be indicated separately by way of notes.
Declaration:
I/We hereby declare that this report is based on the format as prescribed by SEBI (ICDR) Regulations, 2009, as amended. I/We further declare that this report provides true and fair view of the utilization of issue proceeds.
I/We declare that we do not have any direct / indirect interest in or relationship with the
issuer/promoters/directors/management and also confirm that we do not perceive any conflict of interest in such relationship / interest while monitoring and reporting the utilization of issue proceeds by the issuer.
Signature:
Name of the Authorized Person/Signing Authority:
Designation of Authorized person/Signing Authority:
Seal of the Monitoring Agency:
Date:
Subsequent Pages:
1) Issuer Details:
Name of the issuer :
The names of the promoters of the issuer :
Industry/sector to which it belongs :
2) Issue Details:
Issue Period :
Type of issue (public/rights) :
Type of specified securities :
Grading :
Issue size (Rs in Crores) :
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
(Give item by item description for all the objects stated in offer document separately in following format)
| Particulars | Reply | Comments of Monitoring Agency | Comments of Board of Directors |
| Whether all the utilzation is as per disclosure in Offer Document? | Yes/No | ||
| Whether Shareholder approval is obtained in case of material deviations# from expenditures disclosed in Offer Document? | Yes/No | ||
| Whether means of finance for disclosed objects of the Issue has changed? | Yes/No | ||
| Any major deviation observed over the earlier monitoring agency reports? | Yes/No | ||
| Whether all Government / Statutory approvals related to the object(s) obtained? | Yes/No | ||
| Whether all arrangements pertaining to technical assistance/collaboration in operation? | Yes/No | ||
| Any favorable events improving object(s) viability | Yes/No | ||
| Any unfavorable events affecting object(s) viability | Yes/No | ||
| Any other relevant information that may materially affect the decision making of the investors | Yes/No |
# Where material deviation may be defined to mean:
a) Deviation in the objects or purposes for which the funds have been raised
b) Deviation in the amount of fund actually utilized by more than 10% of the amount projected in the offer documents.
4) Details of object(s)s to be monitored:
(i) Cost of object(s)-
(Give Item by Item Description for all the Objects Stated in Offer Document separately in following format)
| Sl. No | Item Head | Original Cost (as per Offer Document) | Revised Cost | Comments of Monitoring Agency | Comments of Board of Directors | ||
| Reason of cost revision | Proposed financing option | Particulars of firm arrangements made | |||||
(ii) Progress in the object(s)-
(Give Item by Item Description for all the Objects Stated in Offer Document separately in the following format)
| Sl. No | Item Head$ | Amount as proposed in Offer Document | Amount utilized | Total unutilized Amount | Comments of Monitoring Agency | Comments of Board of Directors | |||
| As at Beginning of the quarter | During the quarter | At the end of the quarter | Reason of idle funds | Proposed Course of Action |
|||||
$ Provide following details under Item Head:
(a)Name of the object(s):
(b)Brief description of the object(s):
(c)Location of the object(s) (if applicable):
(iii) Deployment of unutilized IPO proceeds-
| Sl. no. | Type of instrument where amount invested* | Amount invested | Maturity date | Earnings | Return on Investment (ROI %) | Market Value as at the end of quarter** |
* Also indicate name of the party/company in which amounts have been invested
** Where market value is not practical to find, provide NAV/NRV/Book Value of the same
(iv) Delay in implementation of the object(s)-
| Object(s) Name | Completion Date | Delay (No. of days/ months) | Comments of Board of Directors | ||
| As per Offer Document | Actual * | Reason of delay | Proposed Course of Action |
||
* In case of continuing object(s) please specify latest/revised estimate of completion date.